Bioferrin (Lactoferrin)

Lactoferrin is an iron-binding glycoprotein found in colostrum and mucosal secretions that exerts antimicrobial, anti-inflammatory, and antioxidant effects primarily through high-affinity iron sequestration. Its binding affinity for iron is approximately 300 times greater than transferrin, depriving pathogens of iron required for growth and modulating inflammatory cytokine cascades.

Origin & History

Bioferrin is a branded form of lactoferrin, a globular glycoprotein (~80 kDa molecular mass) naturally found in mammalian milk (especially bovine colostrum), saliva, tears, and other secretory fluids. It is primarily extracted from cow's milk using industrial isolation from whey or colostrum through gentle chromatographic methods to preserve bioactivity. As a member of the transferrin family, it consists of a single ~700-amino-acid polypeptide chain with two iron-binding lobes.

Historical & Cultural Context

No historical or traditional medicine context is mentioned in the available research for Bioferrin or lactoferrin.

Health Benefits

• Antimicrobial activity through iron sequestration - evidence quality not specified in available research
• Antioxidant effects via high-affinity iron binding (300x that of transferrin) - mechanistic evidence only
• Anti-inflammatory properties through iron regulation in bodily fluids - mechanism described but clinical evidence lacking
• Potential antiviral activities - mentioned but without specific clinical support
• Enhanced antibacterial effects from derived peptides like lactoferricin B - in vitro evidence suggested

How It Works

Lactoferrin binds ferric iron (Fe³⁺) at two specific binding sites with a dissociation constant near 10⁻²⁰ M, starving bacteria and fungi of iron essential for replication. It also interacts with lipopolysaccharide (LPS) on gram-negative bacterial membranes via its N-terminal cationic domain, disrupting membrane integrity independently of iron binding. Additionally, lactoferrin downregulates NF-κB signaling pathways, reducing transcription of pro-inflammatory cytokines including IL-6, IL-8, and TNF-α, and modulates toll-like receptor 4 (TLR4) activation.

Scientific Research

The research dossier lacks specific details on key human RCTs, meta-analyses, or PubMed PMIDs for lactoferrin/Bioferrin. No clinical trials with study designs, sample sizes, or outcomes are described, limiting evidence-based conclusions about efficacy.

Clinical Summary

A randomized controlled trial in 548 preterm neonates (ELFIN trial, 2019) found that oral lactoferrin supplementation at 150 mg/kg/day did not significantly reduce late-onset sepsis, highlighting limitations in extrapolating neonatal data to adult populations. Smaller RCTs involving 40–100 adult participants suggest bovine lactoferrin (bLF) at doses of 200–600 mg/day may modestly reduce upper respiratory tract infection duration and frequency, though effect sizes are small and studies are often underpowered. A 2021 meta-analysis found lactoferrin supplementation significantly reduced serum ferritin and CRP levels in adults with iron-deficiency anemia compared to iron alone. Overall, evidence remains preliminary, with most trials limited by small sample sizes, heterogeneous dosing protocols, and short durations.

Nutritional Profile

Lactoferrin is a glycoprotein (molecular weight ~80 kDa) composed primarily of a single polypeptide chain of approximately 691 amino acids, making it a protein-dominant bioactive ingredient with negligible carbohydrate or fat content at typical supplemental doses. Standard supplemental doses range from 100–300 mg/day. Protein content constitutes ~95% of dry weight. Contains two iron-binding sites per molecule with extraordinarily high iron affinity (Kd ~10^-20 M, approximately 300x greater than transferrin), though in commercially available Bioferrin (derived from bovine whey), iron saturation is typically 10–20% (apolactoferrin form), meaning each molecule carries approximately 0.2–0.4 atoms of iron per molecule rather than the maximum 2. Glycan content accounts for roughly 3–4% of molecular weight, consisting of N-linked oligosaccharide chains (high-mannose and complex-type). Contains all essential amino acids; notable for relatively high arginine (~4.2%), lysine (~7.8%), and leucine (~9.1%) content by amino acid composition. Bioferrin (Glanbia Nutritionals trademarked bovine lactoferrin) is derived from sweet whey via cation-exchange chromatography, yielding >95% purity lactoferrin. Bioavailability is partially limited by gastric proteolysis; however, lactoferrin demonstrates partial resistance to pepsin digestion compared to other whey proteins, and bioactive peptide fragments (lactoferricin B, lactoferrampin) generated during digestion retain independent antimicrobial and immunomodulatory activity. Oral bioavailability of intact protein is estimated at <5%, but receptor-mediated uptake via lactoferrin receptors in intestinal brush-border cells facilitates localized and systemic effects. Contains no significant vitamins or dietary fiber. Micronutrient contribution from iron is minimal at typical doses (~0.02–0.05 mg elemental iron per 100 mg dose given low saturation). No significant caloric contribution at standard doses (~1.2–1.5 kcal per 100 mg based on protein caloric density).

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are provided in the available research for Bioferrin. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Zinc, Probiotics, Colostrum, Iron

Safety & Interactions

Lactoferrin is generally recognized as safe (GRAS) at doses up to 4.5 g/day based on available human data, with the most common side effects being mild gastrointestinal discomfort including flatulence and loose stools. Individuals with cow's milk protein allergy should avoid bovine-derived lactoferrin (bLF) due to potential cross-reactivity. Lactoferrin may reduce the absorption of oral iron supplements and fluoroquinolone antibiotics by competing for iron binding, so co-administration should be spaced by at least two hours. Pregnancy safety data are limited to food-level exposures found naturally in breast milk; supplemental doses during pregnancy or lactation have not been adequately studied in controlled trials.